ALNYLAM PHARMACEUTICALS, INC.: cash_and_equivalents

Value{"amount": 534081000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2022-03-31)
Statuscurrent
EntityALNYLAM PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001178670-22-000016
Retrieved: 2026-08-19T11:51:53.022865+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001178670/cash-and-equivalents/2022-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/9e6b7f07-b7fe-4f43-ab51-1c2e2c7fe072

History